The Institute of Bioengineering (IB) began its constitution process when UMH was established in 1996. The Institute aims to promote high-quality and multidisciplinary research, focusing its efforts on the following areas: cell regenerative therapy, genetics of plant development, cell physiology, biomaterials, biomedical instrumentation, telemedicine, structural and functional genomics, toxicology and chemical safety, neurotoxicity and embryotoxicity, synthesis and design of organic molecules and polymers with biological and electronic applications, cell banks, clinical trials and drug monitoring.
The IB staff includes 39 professors, 52 full-time researchers along with 17 qualified laboratory technicians and administrative personnel. With regard to scientific activity indicators, it should be noted that for the period 2005–2009, the IB obtained funding for R&D activities and infrastructure totaling 12,121,921€, of which 1,424,681€ resulted from R&D contracts for technology transfer. As for its scientific publications, the IB has published 493 articles since its creation with an average impact factor of 3.890.
The IB research groups have high international exposure, participating in European projects on the genetics of plant development, electronic applications in biomedicine, and computer applications in the footwear industry. It collaborates with the European Commission and the European Chemical Agency in safety assessment programs of chemicals in European regulations. It also participates in projects and activities for the promotion and development of alternative testing methods without animal experimentation, photovoltaic and light emitting diodes applications of organic molecules and other projects. The IB presents an environment for supporting and facilitating high quality R&D activities of its academic university members.